APRE Financials
Aprea Therapeutics Inc - Financial statements & key metrics
Stock Price
$0.88
Market Cap
$6.22M
EPS
$-2.12
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
-
Gross Profit
-
Operating Income
-
Net Income
$-12.96M
EPS (Diluted)
$-2.45
Balance Sheet Highlights
Total Assets
$23.98M
Total Liabilities
-
Shareholders Equity
-
Cash & Equivalents
$22.85M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-13.56M
CapEx
-
Free Cash Flow
-
Profitability Metrics
Gross Margin
-1619.1%
Operating Margin
-1686.9%
ROE
-0.7%
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is APRE revenue?
View APRE's income statement for detailed revenue data.
Is APRE profitable?
APRE reported a loss of $12.96M in the most recent quarter.
What is APRE market cap?
APRE has a market capitalization of $6.22M, making it a small-cap stock.
Does APRE have debt?
View APRE's balance sheet for debt information.
What is APRE cash flow?
Cash flow data is available in the full financial statements.